KZR KEZAR LIFE SCIENCES INC Investor Conferences 8-K Filing 2025 - Kezar Presentation On February 27, 2025, Kezar Life Sciences presented a safety update on zetomipzomib for autoimmune hepatitis and lupus nephritis at a virtual event hosted by William Blair.Get access to all SEC 8-K filings of the KEZAR LIFE SCIENCES INC